- Home
- VERA
VERA
Vera Therapeutics Inc.
as 03-28-2025 4:00pm EST
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | BRISBANE |
| Market Cap: | N/A | IPO Year: | 2021 |
| Target Price: | $65.50 | AVG Volume (30 days): | 719.5K |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.75 | EPS Growth: | N/A |
| 52 Week Low/High: | $25.55 - $51.61 | Next Earning Date: | 05-08-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Vera Therapeutics Inc. (VERA)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Fordyce Marshall | VERA | PRESIDENT AND CEO | Feb 21 '25 | Sell | $27.92 | 19,688 | $546,913.71 | 213,740 | |
| Fordyce Marshall | VERA | PRESIDENT AND CEO | Jan 8 '25 | Sell | $41.86 | 17,500 | $730,535.37 | 213,740 |
Latest Vera Therapeutics Inc. News
VERA Breaking Stock News: Dive into VERA Ticker-Specific Updates for Smart Investing
GlobeNewswire
19 days ago
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MT Newswires
a month ago
Wedbush Adjusts Price Target on Vera Therapeutics to $34 From $38, Maintains Neutral Rating
GlobeNewswire
a month ago
Vera Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
MT Newswires
a month ago
Vera Therapeutics 2024 Loss Widens
GlobeNewswire
a month ago
Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
a month ago
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MT Newswires
2 months ago
Wolfe Research Initiates Coverage on Vera Therapeutics With Outperform Rating, $49 Price Target
MT Newswires
2 months ago
Goldman Sachs Initiates Vera Therapeutics at Buy With $58 Price Target
Compare VERA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VERA Vera Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.